Streetbeat News

Price Targets

AX

Axos Financial (NYSE:AX) has been analyzed by 5 analysts, showing a range of ratings from somewhat bullish to indifferent. The average 12-month price target has increased by 12.71% to $79.8. Analysts have adjusted their ratings and price targets, reflecting their views on Axos Financial's performance. The company has shown strong revenue growth and profitability, with a net margin of 36.53% and a ROE of 4.67%.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 8:00 pm

CRM

Salesforce shares rise following an upgrade by Piper Sandler from Neutral to Overweight, with a new price target of $325.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 7:56 pm

CNHI

CNH Industrial shares rose following an upgrade by Raymond James from Market Perform to Outperform, with a new price target of $14.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 7:52 pm

CMA

Comerica (NYSE:CMA) has been analyzed by 14 analysts, showing a range of sentiments from bullish to bearish. The average 12-month price target has increased by 7.17% to $58.86. Analysts have adjusted their ratings and price targets, reflecting their views on Comerica's market position and financial performance.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:02 pm

TXRH

In the past three months, 14 analysts have rated Texas Roadhouse (NASDAQ:TXRH), with a mix of bullish and indifferent sentiments. The average 12-month price target has increased by 4.38% to $183.93. Analysts have adjusted their ratings and price targets, reflecting positive financial performance, including a 14.51% revenue growth rate and strong profitability metrics.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:01 pm

AMZN

CRM

GOOGL

MSFT

ORCL

Piper Sandler analyst Brent Bracelin upgraded Salesforce (CRM) to Overweight, raising the price target to $325, citing potential doubling of free cash flow by 2029 due to AI initiatives. Salesforce's valuation is favorable compared to peers, and new pricing strategies could boost growth. The company is accelerating product updates, particularly in AI, and leveraging strategic partnerships.

Portfolio Pulse from Anusuya Lahiri

September 24, 2024 | 6:40 pm

ABBV

Recent options trading trends for AbbVie (NYSE:ABBV) show a bearish sentiment among large investors, with 40% of trades being bearish. The options activity suggests a price range of $165 to $210. AbbVie's stock is currently neutral with a slight decrease in price.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:30 pm

TXRH

Wedbush analyst Nick Setyan has reiterated an Outperform rating for Texas Roadhouse (NASDAQ:TXRH) and maintained a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:05 pm

GNRC

Piper Sandler analyst Kashy Harrison has reiterated an Overweight rating on Generac Holdings (NYSE:GNRC) with a maintained price target of $175.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:02 pm

BRZE

Braze (NASDAQ:BRZE) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target is $61.15, a decrease from the previous $63.62. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Braze's financial performance shows strong revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm